Bandingkan Harga & Kinerja Kimia Farma Tbk (KAEF) vs Solusi Bangun Indonesia Tbk. (SMCB)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kimia Farma Tbk dan Solusi Bangun Indonesia Tbk.: Kimia Farma Tbk diperdagangkan di Rp452 (kapitalisasi pasar 2,52 T, volume 24 jam 1,17 jt), sedangkan Solusi Bangun Indonesia Tbk. diperdagangkan di Rp775 (kapitalisasi pasar 6,99 T). Perbedaan utamanya: Solusi Bangun Indonesia Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar Kimia Farma Tbk. Mana yang lebih baik tergantung tujuan investasimu.
| KAEF | SMCB | |
|---|---|---|
Kapitalisasi Pasar | 2,52 T | 6,99 T |
Volume | 1,17 jt | — |
Lot | 11,68 rb | — |
Perputaran | 528,04 jt | — |
Harga Rata-rata | 452,05 | — |
Nilai Transaksi | 528,04 jt | — |
Harga Ekuilibrium Indikatif | 452 | — |
Volume Ekuilibrium Indikatif | 42 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kimia Farma Tbk
PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.
Selengkapnya di halaman KAEF →Tentang Solusi Bangun Indonesia Tbk.
PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.
Selengkapnya di halaman SMCB →
